We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Alliance to Develop Biologic Detection Systems

By HospiMedica staff writers
Posted on 20 Aug 2001
A collaboration to develop and design biologic-detection systems for military and other preparedness applications has been announced by Environmental Technologies Group Inc. More...
(ETG, Baltimore, MD, USA) and Cepheid (Sunnyvale, CA, USA). Under the agreement, the two companies will develop systems based on Cepheid's proprietary technologies for the capture, purification, amplification, and detection of DNA.

Cepheid will provide subsystems and sub-assemblies to ETG for integration into, and manufacture of, fully automated bio-detection systems that will range from hand-held units to stationary monitoring systems for use in a variety of military and civilian settings. Cepheid's I-Core and microfluidic technologies will be key components of the DNA detection systems that will be made and marketed on a worldwide basis by ETG and its sister company, Graseby Dynamics Limited, under royalty-bearing licenses from Cepheid. ETG, a part of Smiths Aerospace (London, UK), is a leading provider of full-service, advanced engineering technology for nuclear, biologic, and chemical detection systems.

"ETG is the ideal partner to adapt Cepheid's versatile DNA testing technology to the bio-defense market, and together we are committed to developing systems that deliver faster, more sensitive results under any conditions,” said Tom Gutshall, chairman and CEO of Cepheid.




Related Links:
Cepheid
Graseby Dynamics

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
New
Gold Member
Fully-auto Specific Protein (Nephelometry) Analyzer
PA240
Hematology Consumables
Bioblood Devices
Thyroid Test
Anti-Thyroid EIA Test
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image Credit: Adobe Stock

Blood Biomarkers Help Assess Growth Risks During Steroid Treatment in Duchenne Muscular Dystrophy

Children with Duchenne muscular dystrophy (DMD) commonly receive long-term corticosteroids to slow disease progression, but these drugs can impair linear growth and weaken bone. Understanding how specific... Read more

Molecular Diagnostics

view channel
Image: The Xpert Hemorrhagic Fever Panel test runs on Cepheid’s GeneXpert Dx systems (Photo courtesy of Cepheid)

WHO Emergency Listing Supports Rapid Molecular Testing for Ebola Outbreak Response

The Democratic Republic of the Congo is confronting an Ebola Bundibugyo outbreak that the World Health Organization (WHO) designated a Public Health Emergency of International Concern on May 17, 2026.... Read more

Microbiology

view channel
Image Credit: Adobe Stock

Gut Microbiome Classifier Improves Colorectal Cancer Risk Stratification

Colorectal cancer remains a leading cause of cancer mortality, and current noninvasive screening methods still miss many precancerous lesions. Clinicians therefore need tools that improve risk stratification... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.